Outpatient consolidation treatment with clofarabine in a phase 2 study of older adult patients with previously untreated acute myelogenous leukemia-Reference-Cited by-同舟云学术

Outpatient consolidation treatment with clofarabine in a phase 2 study of older adult patients with previously untreated acute myelogenous leukemia

Published:2011-10-24 Issue:3 Volume:53 Page:435-440
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Claxton David,Erba Harry P.,Faderl Stefan,Arellano Martha,Lyons Roger M.,Kovacsovics Tibor,Gabrilove Janice,Huebner Dirk,Gandhi Pritesh J.,Kantarjian Hagop,

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2011.616960

Reference20 articles.

1. Age and acute myeloid leukemia

3. Acute Myeloid Leukemia and Myelodysplastic Syndromes in Older Patients

4. Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.

5. A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloid Malignancies;Side Effects of Medical Cancer Therapy;2018

2. Physiological and pathological implications of 5-hydroxymethylcytosine in diseases;Oncotarget;2016-05-10

3. Control of relapsed or refractory acute myeloid leukemia by clofarabine in preparation for allogeneic stem cell transplant;Leukemia & Lymphoma;2015-09-24

4. New drug toxicities in the onco-nephrology world;Kidney International;2015-05

5. The role of Clofarabine in the treatment of adults with acute myeloid leukemia;Critical Reviews in Oncology/Hematology;2015-03